Coronavirus Analysis
Deloitte: The Post-COVID-19 Shutdown Rebound: How Medtech Companies Can Help Support Deferred Care and Procedure Recovery
The COVID-19 pandemic is testing medical technology companies’ ability to flex operations and help healthcare providers manage demand surges arising from the resumption of deferred care and procedures. To help support the rebound—and prepare for COVID-19’s potential long-term impacts on product, supply chain, and ecosystem capabilities—organizations should rethink their short- and long-term commercial effectiveness strategies. By Doug Billings, Deloitte Consulting LLP.
